VY-NAV-01

N/A

Report date: 2025/01/26 16:27:56

Base Information

Drug NameVY-NAV-01

Drug Alias NameSCN9A (Nav1.7) gene therapy (AAV) (Voyager)SCN9A sodium channel subunit (Nav1.7) gene therapy (adeno-associated viral vector) (Voyager)VY-NAV-01

ClassificationBiologics

Mechanisms of ActionSodium channel protein type IX alpha subunit blockers

TargetsSodium channel protein type IX alpha subunit

Therapy Area/IndicationsPain

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVoyager Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesVoyager Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsPain

Inactive IndicationsN/A

Other Information

ATC CodeN/A